ATRX and glioma: The ATRX KO malignant glioma cell lines incorporated EdU similar to the ATRX WT cell lines, indicating that ATRX KO cells replicate and proliferate at normal rates (Figure S3C), which is important to assess the toxicity caused by the drug treatments.